A Multi-center, Randomized, Pilot Trial to Evaluate the My Hematology Oncology Patient Experience (MYHOPE™) for Multiple Myeloma (MM) Digital Care Network in Patients With MM

Monthly eligibility and recruitment rates per month of patients with multiple myeloma

时间窗: Up to 12 months

is defined as the number of patients with MM that satisfied entry criteria per study site/month)

Duration of follow-up

时间窗: Up to 6 months

is defined as the mean, median, and range of time from each user's first login to his or her last login to the Patient App or to the HCP Portal

Frequency of user access by feature and by month, relative to the enrollment date of each participant

时间窗: Up to 6 months

Is defined as how often patients access various features of the app, per month relative to the enrollment date of each participant

Patient empowerment and self-efficacy measured by CASE-Cancer

时间窗: Up to 6 months

The instrument consists of 3 subscales: understanding and participating in care, maintaining a positive attitude, and seeking and obtaining information. All items are scored on a range of 1 to 4 from strongly disagree to strongly agree, with higher score indicating better empowerment

User average weekly log-in rates over the duration of follow-up from patients with MM and HCPs

时间窗: Up to 6 months

is defined as the number of times a user attempts to log in/week

Patient-reported outcome completion rates

时间窗: Up to 6 months

Is defined as the number of data points that are completed divided by the number of data points that could have been completed at each specified timepoint, relative to the enrollment date of each participant

Percentage of patients for whom the HCPs complete the 6-month assessments

时间窗: up to 18 months

is defined as number of patients for whom HCPs provided 6-month assessments \[eg, disease response assessments\] divided by the number of patients for whom HCPs provided baseline data)